Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Long-Term Debt Repayments: 2020-2025

Historic Long-Term Debt Repayments for Aytu Biopharma (AYTU) over the last 5 years, with Sep 2025 value amounting to $464,000.

  • Aytu Biopharma's Long-Term Debt Repayments changed negligibly% to $464,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 88.51%. This contributed to the annual value of $1.9 million for FY2025, which is 88.19% down from last year.
  • Latest data reveals that Aytu Biopharma reported Long-Term Debt Repayments of $464,000 as of Q3 2025, which was down 0.00% from $464,000 recorded in Q2 2025.
  • Aytu Biopharma's Long-Term Debt Repayments' 5-year high stood at $89.6 million during Q4 2021, with a 5-year trough of -$73.6 million in Q1 2022.
  • For the 3-year period, Aytu Biopharma's Long-Term Debt Repayments averaged around $1.6 million, with its median value being $464,000 (2025).
  • Its Long-Term Debt Repayments has fluctuated over the past 5 years, first crashed by 163,560.00% in 2022, then soared by 67,952.17% in 2024.
  • Over the past 5 years, Aytu Biopharma's Long-Term Debt Repayments (Quarterly) stood at $89.6 million in 2021, then crashed by 100.03% to -$26,000 in 2022, then soared by 188.46% to $23,000 in 2023, then soared by 1,921.74% to $465,000 in 2024, then remained steady at $464,000 in 2025.
  • Its last three reported values are $464,000 in Q3 2025, $464,000 for Q2 2025, and $464,000 during Q1 2025.